Jennifer Jaroscak to Graft vs Host Disease
This is a "connection" page, showing publications Jennifer Jaroscak has written about Graft vs Host Disease.
Connection Strength
0.329
-
Outcomes Using Narrowband UVB Phototherapy for Acute Cutaneous Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients. J Pediatr Hematol Oncol. 2021 01; 43(1):e151-e153.
Score: 0.150
-
Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003 Jun 15; 101(12):5061-7.
Score: 0.044
-
The effect of bone marrow graft composition on pediatric bone marrow transplantation outcomes. Pediatr Transplant. 2018 12; 22(8):e13287.
Score: 0.032
-
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood. 2016 11 24; 128(21):2561-2567.
Score: 0.028
-
Alemtuzumab based reduced intensity transplantation for pediatric severe aplastic anemia. Pediatr Blood Cancer. 2015 Jul; 62(7):1270-6.
Score: 0.025
-
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood. 2010 Dec 02; 116(23):5045-9.
Score: 0.018
-
Clinical and immunologic outcomes following haplocompatible donor lymphocyte infusions. Bone Marrow Transplant. 2009 Dec; 44(12):805-12.
Score: 0.017
-
Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults. Br J Haematol. 2007 Nov; 139(3):464-74.
Score: 0.015